{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T23:54:58Z","timestamp":1771458898372,"version":"3.50.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/bor.0b013e32835ad3ca","type":"journal-article","created":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T09:00:14Z","timestamp":1352365214000},"page":"19-25","source":"Crossref","is-referenced-by-count":65,"title":["Thrombosis in vasculitis"],"prefix":"10.1097","volume":"25","author":[{"given":"Jason","family":"Springer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Villa-Forte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210128","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(11)61306-8","article-title":"Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden.","volume":"379","author":"Zoller","year":"2012","journal-title":"Lancet"},{"key":"R2-6-20210128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2377-12-41","article-title":"Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden.","volume":"12","author":"Zoller","year":"2012","journal-title":"BMC Neurol"},{"key":"R3-6-20210128","doi-asserted-by":"crossref","first-page":"e33442","DOI":"10.1371\/journal.pone.0033442","article-title":"Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden.","volume":"7","author":"Zoller","year":"2012","journal-title":"PLoS One"},{"key":"R4-6-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-9-1","article-title":"Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study.","volume":"9","author":"Ramagopalan","year":"2011","journal-title":"BMC Med"},{"key":"R5-6-20210128","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/art.11454","article-title":"Thrombosis and pediatric Wegeners granulomatosis: acquired and genetic risk factors for hypercoagulability.","volume":"49","author":"von Scheven","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R6-6-20210128","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegeners granulomatosis.","volume":"352","year":"2005","journal-title":"N Engl J Med"},{"key":"R8-6-20210128","doi-asserted-by":"crossref","first-page":"49","DOI":"10.11613\/BM.2012.006","article-title":"Inflammation and haemostasis.","volume":"22","author":"Margetic","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"key":"R9-6-20210128","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.avsg.2010.09.003","article-title":"Interleukin-6: a potential target for postthrombotic syndrome.","volume":"25","author":"Wojcik","year":"2011","journal-title":"Ann Vasc Surg"},{"key":"R10-6-20210128","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/1076029611405032","article-title":"Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis.","volume":"17","author":"Ramacciotti","year":"2011","journal-title":"Clin Appl Thromb Hemost"},{"key":"R12-6-20210128","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1160\/TH07-10-0608","article-title":"Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation.","volume":"99","author":"Meier","year":"2008","journal-title":"Thromb Haemost"},{"key":"R13-6-20210128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/03009740500255761","article-title":"Characteristics of vascular involvement in Behcets disease.","volume":"35","author":"Duzgun","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"R14-6-20210128","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00296-010-1603-2","article-title":"Investigation of the veins in patients with Behcets disease with no known vascular event by Doppler ultrasonography.","volume":"32","author":"Kisacik","year":"2012","journal-title":"Rheumatol Int"},{"key":"R15-6-20210128","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/art.34450","article-title":"Immunosuppressants reduce venous thrombosis relapse in Behcets disease.","volume":"64","author":"Desbois","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R16-6-20210128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10067-007-0685-z","article-title":"Treatment of venous thrombosis associated with Behcets disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation.","volume":"27","author":"Ahn","year":"2008","journal-title":"Clin Rheumatol"},{"key":"R17-6-20210128","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00415-010-5885-9","article-title":"Cerebral venous thrombosis in Behcets disease: a systematic review.","volume":"258","author":"Aguiar de Sousa","year":"2011","journal-title":"J Neurol"},{"key":"R18-6-20210128","first-page":"858","article-title":"Budd-Chiari syndrome: a common complication of Behcets disease.","volume":"92","author":"Bayraktar","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"R19-6-20210128","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.gcb.2007.12.022","article-title":"Budd-Chiari syndrome associated with Behcets disease.","volume":"32","author":"Ben Ghorbel","year":"2008","journal-title":"Gastroenterol Clin Biol"},{"key":"R20-6-20210128","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/art.24393","article-title":"Cerebral venous thrombosis in Behcets disease.","volume":"61","author":"Saadoun","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R21-6-20210128","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s00415-009-5088-4","article-title":"Cerebral venous thrombosis in Behcets disease compared to those associated with other etiologies.","volume":"256","author":"Yesilot","year":"2009","journal-title":"J Neurol"},{"key":"R22-6-20210128","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/15569527.2011.554480","article-title":"Oxidative stress impairs endothelial nitric oxide levels in Behcets disease.","volume":"30","author":"Onur","year":"2011","journal-title":"Cutan Ocul Toxicol"},{"key":"R23-6-20210128","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.1468-3083.2011.04280.x","article-title":"Associations between eNOS polymorphisms and susceptibility to Behcets disease: a meta-analysis.","volume":"26","author":"Lee","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R24-6-20210128","first-page":"87","article-title":"Activated protein C resistance and its correlation with thrombophlebitis in Behcets disease.","volume":"19","author":"Kavala","year":"2011","journal-title":"Acta Dermatovenerol Croat"},{"key":"R25-6-20210128","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.thromres.2011.07.032","article-title":"Haplotypes of the endothelial protein C receptor gene and Behcets disease.","volume":"129","author":"Navarro","year":"2012","journal-title":"Thromb Res"},{"key":"R26-6-20210128","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCRESAHA.110.233056","article-title":"3rd, Mackman N. Microparticles in hemostasis and thrombosis.","volume":"108","author":"Owens","year":"2011","journal-title":"Circ Res"},{"key":"R27-6-20210128","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1093\/rheumatology\/ker177","article-title":"Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behcets disease.","volume":"50","author":"Macey","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R28-6-20210128","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Behcets syndrome.","volume":"322","author":"Yazici","year":"1990","journal-title":"N Engl J Med"},{"key":"R29-6-20210128","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-142-8-200505030-00011","article-title":"Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegeners Clinical Occurrence of Thrombosis (WeCLOT) Study.","volume":"142","author":"Merkel","year":"2005","journal-title":"Ann Intern Med"},{"key":"R30-6-20210128","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/ard.2008.099051","article-title":"High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegeners granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients.","volume":"68","author":"Allenbach","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R31-6-20210128","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa0900241","article-title":"A randomized trial of rosuvastatin in the prevention of venous thromboembolism.","volume":"360","author":"Glynn","year":"2009","journal-title":"N Engl J Med"},{"key":"R32-6-20210128","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11239-012-0687-9","article-title":"Statins, inflammation and deep vein thrombosis: a systematic review.","volume":"33","author":"Rodriguez","year":"2012","journal-title":"J Thromb Thrombolysis"},{"key":"R33-6-20210128","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1002\/art.24957","article-title":"Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study.","volume":"60","author":"Morgan","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R34-6-20210128","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/art.24386","article-title":"Increased morbidity from ischemic heart disease in patients with Wegeners granulomatosis.","volume":"60","author":"Faurschou","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R35-6-20210128","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/acr.20433","article-title":"A model to predict cardiovascular events in patients with newly diagnosed Wegeners granulomatosis and microscopic polyangiitis.","volume":"63","author":"Suppiah","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R36-6-20210128","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/rheumatology\/ken035","article-title":"Venous thromboembolism in ANCA-associated vasculitis: incidence and risk factors.","volume":"47","author":"Stassen","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"R37-6-20210128","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1681\/ASN.2008030270","article-title":"Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitis.","volume":"19","author":"Bautz","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R38-6-20210128","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm968","article-title":"3rd, Preston GA, Shah RR, et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3.","volume":"10","author":"Pendergraft","year":"2004","journal-title":"Nat Med"},{"key":"R39-6-20210128","first-page":"2446","article-title":"The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegeners granulomatosis with and without history of a thrombotic event.","volume":"34","author":"Sebastian","year":"2007","journal-title":"J Rheumatol"},{"key":"R40-6-20210128","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood-2006-02-004945","article-title":"Eosinophils are a major intravascular location for tissue factor storage and exposure.","volume":"109","author":"Moosbauer","year":"2007","journal-title":"Blood"},{"key":"R41-6-20210128","doi-asserted-by":"crossref","first-page":"670","DOI":"10.2174\/157016112801784594","article-title":"Hypereosinophilic Syndrome, Churg-Strauss Syndrome and parasitic diseases: possible Links between Eosinophilia and Thrombosis.","volume":"10","author":"Maino","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"R42-6-20210128","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1177\/1076029609348647","article-title":"Eosinophilia and thrombophilia in churg strauss syndrome: a clinical and pathogenetic overview.","volume":"16","author":"Ames","year":"2010","journal-title":"Clin Appl Thromb Hemost"},{"key":"R43-6-20210128","first-page":"221","article-title":"Takayasu arteritis and giant cell arteritis: a spectrum within the same disease Medicine (Baltimore","volume":"88","author":"Maksimowicz-McKinnon","year":"2009","journal-title":")"},{"key":"R44-6-20210128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3988\/jcn.2012.8.2.109","article-title":"Ischemic stroke in Takayasus Arteritis: lesion patterns and possible mechanisms.","volume":"8","author":"Hwang","year":"2012","journal-title":"J Clin Neurol"},{"key":"R45-6-20210128","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.20171","article-title":"Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.","volume":"50","author":"Nesher","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R46-6-20210128","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1253\/circj.CJ-09-0905","article-title":"Antiplatelet therapy for the prevention of arterial ischemic events in takayasu arteritis.","volume":"74","author":"de Souza","year":"2010","journal-title":"Circ J"},{"key":"R47-6-20210128","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.semarthrit.2006.10.001","article-title":"Statin therapy does not seem to benefit giant cell arteritis.","volume":"36","author":"Narvaez","year":"2007","journal-title":"Semin Arthritis Rheum"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0b013e32835ad3ca","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:04:37Z","timestamp":1620947077000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201301000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e32835ad3ca","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}